Filter
1698
Filtered Results: 1698
Text search:
adverse
reactions
Featured
Recommendations
202
New Publications
465
Language
Document type
No document type
1011
Guidelines
302
Studies & Reports
175
Manuals
103
Strategic & Response Plan
35
Fact sheets
34
Training Material
21
Situation Updates
6
Brochures
4
Infographics
4
Resource Platforms
2
Online Courses
1
Countries / Regions
India
111
South Africa
50
Global
43
Western and Central Europe
39
Ethiopia
39
Kenya
37
Nigeria
37
Tanzania
30
Uganda
29
Nepal
28
Latin America and the Carribbean
25
Zambia
24
Malawi
22
Ghana
21
Sierra Leone
19
Philippines
18
Africa
17
Eastern Europe
17
Bangladesh
16
Liberia
16
Rwanda
13
Zimbabwe
13
Namibia
13
Cambodia
12
South–East Asia Region
12
Myanmar / Burma
12
Indonesia
10
Ukraine
9
Lesotho
8
Botswana
8
Eswatini/ Swaziland
8
USA
7
Congo, Democratic Republic of
7
Asia
6
Colombia
5
Syria
5
Senegal
5
Middle East and North Africa
5
East and Southern Africa
5
Germany
4
West and Central Africa
4
Eastern Europe and Central Asia
4
Brazil
4
South Sudan
4
Thailand
3
Mozambique
3
Haiti
3
Western Pacific Region
3
Argentina
3
Moldova
3
Timor Leste/ East Timor
2
Benin
2
Cameroon
2
Afghanistan
2
Guinea
2
Venezuela
2
Bolivia
2
Lebanon
2
Sri Lanka
2
Russia
2
Bhutan
2
Ecuador
2
Tajikistan
1
North Korea
1
Australia
1
Gambia
1
China
1
Kazakhstan
1
Chile
1
Fiji
1
Laos
1
Kyrgyzstan
1
Burkina Faso
1
Ireland
1
Paraguay
1
North America
1
United Kingdom
1
Spain
1
Côte d’Ivoire / Ivory Coast
1
Vietnam
1
Yemen
1
Palestine
1
Georgia
1
Mali
1
Angola
1
Libya
1
Iraq
1
Somalia
1
Solomon Islands
1
Madagascar
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
596
Clinical Guidelines
244
Public Health
82
Women & Child Health
63
Key Resources
50
Capacity Building
29
Pharmacy & Technologies
25
Toolboxes
TB
172
Mental Health
151
COVID-19
137
HIV
106
Pharmacy
88
NTDs
65
Rapid Response
51
AMR
43
Ebola
40
Planetary Health
39
Caregiver
36
Refugee
26
NCDs
26
Conflict
24
Specific Hazards
22
Polio
19
Zika
16
Disability
11
Natural Hazards
10
Cholera
10
Global Health Education
9
Health Financing Toolbox
3
The Committee discussed the implications for preparedness for smallpox-like events reflected by the ongoing COVID-19 pandemic. The Committee noted how quickly diagnostics and vaccines could be developed and deployed when resources and political will were abundant. This rapidity was also due to the f...
El presente decálogo expone de manera concisa los aspectos esenciales de la enfermedad y recoge 10 puntos básicos, esquemáticos y orientados a la práctica para la atención pediátrica de la enfermedad de Chagas.
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons...
his profile is part of a series of Climate Risk Country Profiles developed by the World Bank Group (WBG). The country profile
synthesizes most relevant data and information on climate change, disaster risk reduction, and adaptation actions and policies
at the country level. The country profile ser...
This Commission report aims to contribute to a new era of multilateral cooperation based on strong UN institutions to reduce the dangers of COVID-19, forestall the next pandemic, and enable the world to achieve the agreed goals of sustainable development, human rights, and peace that governments are...
The objective of Health in the Americas: Overview of the Region of the Americas in the Context of the COVID-19 Pandemic is to respond to the need to address important public health issues in an increasingly timely manner, while serving as a platform with a close focus on specific issues of regional ...
The Quadripartite Organizations – the Food and Agriculture Organization of the United Nations (FAO), the United Nations Environment Programme (UNEP), the World Organisation for Animal Health (WOAH, founded as OIE), and the World Health Organization (WHO) – collaborate to drive the change and tra...
This Mpox SPRP Global Monitoring & Evaluation (M&E) Framework, also referred to as the Framework, aims to monitor and report on global progress towards these objectives, including information about country-level response efforts and WHO support to Member States. Regular collection and analysis of da...
Not long ago, on the occasion of the 100th anniversary of the discovery of Chagas disease, several campaigns denounced the scant progress has been made in diffrent spheres- medical, scientific and politcal- but major challanges still remain. This is an appropriate time to celebrate what has been ach...
This guideline for the prevention and control of chikungunya fever
(CF) is intended for use by all peripheral health workers in the Region and
is based on the strategy outlined above. This document will focus mainly
on preventing, predicting and detecting outbreaks, and after detection,
investig...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread drug resistance in HAT patients wher...
In support of the London Declaration goals, PATH aims to catalyze engagement of the diagnostics industry and product development efforts. As part of this work, PATH conducted a diagnostic landscape analysis to identify gaps and evaluated current and nascent HAT diagnostics that may provide solutions...
Cholera which disproportionally impacts poor countries and the most vulnerable continues to affect at least 47 countries across the globe, resulting in an estimated 1.3 – 4 million cases, and 21,000 - 143,000 deaths per year worldwide. In Ethiopia, despite major improvements seen in the increasing...
This analysis focused on the chronic form of HAT caused by T. b. gambiense, as it contributes to the majority of disease burden. Information from the literature review,
product development landscape, and stakeholder interviews was compiled to:
- Identify use cases and understand current diagnosti...
The desired impact of the OH JPA is a world better able to prevent, predict, detect and
respond to health threats and improve the health of humans, animals, plants and the
environment while contributing to sustainable development. The OH JPA aims to work
towards this vision in the following way:
...
В дорожной карте по борьбе с забытыми тропическими болезнями на 2021–2030 гг. («дорожная карта») определены глобальные цели и основные этапы в отношении борьбы с 20 бол...
Building on the 2021 Interim guidance, this second version and update, incorporates the lessons and feedback from the hepatitis pilots that successfully demonstrated the feasibility of measuring hepatitis B and C impact targets to demonstrate elimination, whilst highlighting challenges caused by hig...
This report is one of the first major products of the newly established Precision Public Health Metrics unit of the UCN cluster of the WHO Regional Office for Africa. The report presents national trends in communicable and non-communicable disease burden and control in the WHO African region. It tra...
Mpox is a zoonotic disease caused by a double-stranded DNA virus that belongs to the Orthopoxvirus genus of the Poxviridae family. The disease presents with symptoms similar to smallpox but with a lesser severity. It was first discovered in 1958 when two outbreaks of a poxlike disease occurred in co...
